Stocklytics Platform
Asset logo for symbol PRVA
Privia Health Group
PRVA56
$22.83arrow_drop_down0.80%-$0.18
Asset logo for symbol PRVA
PRVA56

$22.83

arrow_drop_down0.80%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Privia Health Group (PRVA) Stocklytics Forecast

Privia Health Group, Inc. (PRVA) is a healthcare company that is revolutionizing the way patients receive care and interact with their healthcare providers. With a focus on value-based care and patient-centered solutions, Privia Health Group is poised to make a significant impact in the healthcare industry. As a leader in population health management, Privia Health Group leverages advanced technology and data analytics to deliver personalized care plans and improve health outcomes. By partnering with healthcare providers and health systems, Privia Health Group is able to enhance the delivery of care and reduce costs for patients.
In terms of the stock price prediction for Privia Health Group, Inc. (PRVA), it is important to consider various factors that may influence the future performance of the company. One key factor to consider is the company's financials, including revenue growth, profitability, and cash flow. Additionally, market trends and industry dynamics can also impact the stock price of Privia Health Group, Inc. (PRVA).
add Privia Health Group to watchlist

Keep an eye on Privia Health Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Privia Health Group (PRVA) stock?

Analysts have set a target price of $36.72 for Privia Health Group (PRVA), based on forecasts from 29 analysts. The predicted price range extends from a high of $54 to a low of $21. This represents a potential increase of up to 136.48% and a decrease of -8.04% from the current price of $22.84. These forecasts are as of 2022 May 13.
help

What are the analyst ratings for Privia Health Group (PRVA) stock?

The analyst ratings for Privia Health Group (PRVA) are distributed as follows: 18 analysts recommend buying, 2 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 20 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Privia Health Group.
help

What is the AI price prediction for Privia Health Group (PRVA) stock?

At present, there is no AI or machine-learning-based price prediction available for Privia Health Group (PRVA) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level